Oxcarbazepine NDC 60505-4129

NDC codes

FDA NDC Directory

Product NDC (as listed)60505-4129Labeler and product segments. Claims need a package NDC.

Product NDC at billing width60505-4129Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
60505-4129-5	60505412905	500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4129-5)Marketed from Sep 3, 2024
60505-4129-7	60505412907	100 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-4129-7)Marketed from Sep 3, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxcarbazepine
Generic name (nonproprietary): oxcarbazepine
Active ingredients: Oxcarbazepine — 300 mg/1
Dosage form: Tablet, Extended release
Route: Oral
Labeler: Apotex Corp.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 213369
Marketing start: Sep 3, 2024
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 60505-4129_3bf45238-ec14-8f5d-8744-4b94339a3799SPL ID 3bf45238-ec14-8f5d-8744-4b94339a3799
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N460505412905 followed by a unit qualifier and the quantity

Package 60505-4129-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under ANDA 213369

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 213369
Product	Strength	Form · route	Labeler	Product NDC
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-4128
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Extended releaseOral	Apotex Corp.	60505-4130